Related Experiment Video

Updated: Jun 20, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Markers of inflammation and risk of coronary heart disease

Nadeem Sarwar1, Alexander J Thompson, Emanuele Di Angelantonio

  • 1Section of Population Health, University of Aberdeen, UK Department of Public Health and Primary Care, University of Cambridge, UK. n.sarwar@abdn.ac.uk

Disease Markers
|September 24, 2009
PubMed

Insights

Inflammation markers like C-reactive protein are linked to coronary heart disease (CHD) risk. This review examines evidence for four key markers, assessing their role in predicting cardiovascular disease.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biology
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) is the primary cause of global mortality.
  • Coronary heart disease (CHD) is the most prevalent form of CVD.
  • Inflammation plays a role in CHD development, but its link to circulating markers and risk is unclear.

Purpose of the Study:

  • To review epidemiological evidence for four emerging inflammatory markers in CHD.
  • To evaluate the utility of these markers in cardiovascular risk prediction.
  • To identify areas needing further research regarding inflammation and CHD.

Main Methods:

  • Literature review of epidemiological studies.
  • Focus on fibrinogen, C-reactive protein, lipoprotein-associated phospholipase A2, and interleukin-6.
  • Analysis of marker relevance to CHD risk and prediction.

Main Results:

  • Summarizes evidence linking specific inflammatory markers to CHD.
  • Assesses the predictive value of these markers for cardiovascular events.
  • Highlights existing uncertainties in the field.

Conclusions:

  • Inflammatory markers show potential in understanding and predicting CHD risk.
  • Further research is needed to clarify their precise role and clinical application.
  • Understanding inflammation's role is crucial for combating cardiovascular mortality.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...